A detailed history of Simplex Trading, LLC transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 815 shares of AMPH stock, worth $39,136. This represents 0.0% of its overall portfolio holdings.

Number of Shares
815
Holding current value
$39,136
% of portfolio
0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

BUY
$38.65 - $43.48 $31,499 - $35,436
815 New
815 $32,000
Q2 2023

Aug 04, 2023

BUY
$35.77 - $58.38 $7,010 - $11,442
196 New
196 $11,000
Q4 2022

Feb 02, 2023

BUY
$27.93 - $31.27 $7,792 - $8,724
279 New
279 $7,000
Q2 2021

Aug 12, 2021

BUY
$17.11 - $20.92 $13,688 - $16,736
800 New
800 $16,000
Q4 2020

Feb 02, 2021

SELL
$17.76 - $21.24 $11,153 - $13,338
-628 Closed
0 $0
Q3 2020

Oct 14, 2020

BUY
$17.99 - $22.22 $9,498 - $11,732
528 Added 528.0%
628 $11,000
Q2 2020

Jul 13, 2020

BUY
$14.25 - $22.46 $1,425 - $2,246
100 New
100 $2,000
Q4 2019

Feb 05, 2020

SELL
$17.07 - $20.64 $9,422 - $11,393
-552 Closed
0 $0
Q3 2019

Oct 15, 2019

SELL
$19.12 - $22.62 $5,908 - $6,989
-309 Reduced 35.89%
552 $10,000
Q2 2019

Jul 26, 2019

BUY
$18.92 - $22.96 $16,290 - $19,768
861 New
861 $18,000
Q1 2019

Apr 18, 2019

SELL
$19.46 - $25.28 $10,099 - $13,120
-519 Closed
0 $0
Q4 2018

Jan 16, 2019

BUY
$17.72 - $22.51 $1,204 - $1,530
68 Added 15.08%
519 $10,000
Q3 2018

Oct 23, 2018

BUY
$15.39 - $19.38 $1,154 - $1,453
75 Added 19.95%
451 $8,000
Q2 2018

Jul 30, 2018

BUY
$14.63 - $19.6 $5,500 - $7,369
376 New
376 $5,000
Q4 2017

Jan 10, 2018

SELL
$17.76 - $19.75 $35,076 - $39,006
-1,975 Closed
0 $0
Q3 2017

Oct 25, 2017

BUY
$14.73 - $17.99 $29,091 - $35,530
1,975
1,975 $35,000

Others Institutions Holding AMPH

About Amphastar Pharmaceuticals, Inc.


  • Ticker AMPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 49,015,200
  • Market Cap $2.35B
  • Description
  • Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...
More about AMPH
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.